Breast cancer patients diagnosed under 35 have higher risk of disease spreading On 2021-11-03 We use your sign-up to provide content in ways you’ve consented to and to improve our understanding of you. This […]
MRI Screening Cost-Effective for Women With Dense Breasts On 2021-09-30 For women with extremely dense breasts, screening with MRI alone every 4 years is cost-effective and delivers the greatest benefit, […]
New genetic classifier can predict the sensitivity of neoadjuvant chemotherapy for breast cancer On 2021-09-15 A research team by Prof. Yang Wulin and Dai Haiming from the Hefei Institutes of Physical Science (HFIPS) of the […]
Study offers hope for an era of safer chemotherapy in breast cancer On 2021-08-23 Breast cancer is the deadliest and most common type of cancer in women. The treatment options often require administration of […]
FDA Warns Again About Robotic Mastectomy, Breaks New Ground On 2021-08-20 The US Food and Drug Administration (FDA) today issued a new safety communication about the use of robotically assisted mastectomy, […]
Out-of-Pocket Costs for MRI Breast Cancer Screening Hitting More Women On 2021-08-02 (Reuters Health) — Increasing numbers of women who need MRI screening for breast cancer are being hit by high out-of-pocket […]
New genomics workbook helps people use their family history to assess disease risks On 2021-07-09 Researchers at the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), have developed the […]
Freezing Breast Cancer to Death Avoids Surgery On 2021-05-10 In the United States, cryoablation or freezing tissue to death is a primary treatment option for a variety of cancers, […]
YAP inhibitors could facilitate targeted treatment of basal-like breast cancer On 2021-03-23 Targeted treatment of basal-like breast cancer could be facilitated by YAP inhibitors in the future. As reported by an MDC […]
No Benefit Seen With Everolimus in Early Breast Cancer On 2021-03-08 Adding everolimus to adjuvant hormone therapy for early ER+, HER2- breast cancer does not offer any benefit over hormone therapy […]